Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

Masatomo Taniguchi, Masafumi Fukagawa, Naohiko Fujii, Takayuki Hamano, Tetsuo Shoji, Keitaro Yokoyama, Shigeru Nakai, Takashi Shigematsu, Kunitoshi Iseki, Yoshiharu Tsubakihara

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Mineral metabolism affects mortality in hemodialysis patients and is identified by imbalances in serum phosphate (P), calcium (Ca), and parathyroid hormone (PTH). We examined associations between annual mineral values (P, Ca, PTH) and mortality in a 3-year cohort (Dec 2006-2009) of 128125 hemodialysis patients using three models, that is, baseline, time-dependent and time-average Cox models. We also examined associations between achieved Japanese guideline targets (P: 3.5-6.0mg/dL, corrected Ca 8.4-10.0mg/dL, intact PTH 60-180mg/dL) and all-cause survival to elucidate which parameter should be controlled as a priority. High and low serum P (>6.0 or ≤3.5mg/dL), high Ca (>9.5mg/dL), higher PTH (>300pg/mL) and lower PTH (≤60pg/mL) were significantly associated with high mortality in all three models (P<0.01). When we examined the association between combination of mineral targets and mortality, patients who achieved all targets simultaneously (20% of subjects, reference) showed lowest mortality. Those who achieved both P and Ca targets showed the same mortality as the reference group. Those who only met P target had a lower risk of death (hazard ratio=1.17) compared to those that achieved Ca or PTH target (1.41, 1.47, respectively). As time of achieving P and Ca targets increased, all-cause mortalities diminished incrementally, significantly. Mineral metabolism disorder would lead to high mortality in prevalent hemodialysis patients. Among mineral values, P would be the strongest predictor for high mortality. Consistent achievement of P and Ca targets would lead to good survival.

Original languageEnglish (US)
Pages (from-to)221-228
Number of pages8
JournalTherapeutic Apheresis and Dialysis
Volume17
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Renal Dialysis
Parathyroid Hormone
Mortality
Calcium
Serum
Minerals
calcium phosphate
Survival
Proportional Hazards Models
Guidelines

Keywords

  • Chronic kidney disease-mineral and bone disorders
  • Guidelines
  • Japan
  • Mortality
  • Priority

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Taniguchi, M., Fukagawa, M., Fujii, N., Hamano, T., Shoji, T., Yokoyama, K., ... Tsubakihara, Y. (2013). Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients. Therapeutic Apheresis and Dialysis, 17(2), 221-228. https://doi.org/10.1111/1744-9987.12030

Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients. / Taniguchi, Masatomo; Fukagawa, Masafumi; Fujii, Naohiko; Hamano, Takayuki; Shoji, Tetsuo; Yokoyama, Keitaro; Nakai, Shigeru; Shigematsu, Takashi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu.

In: Therapeutic Apheresis and Dialysis, Vol. 17, No. 2, 04.2013, p. 221-228.

Research output: Contribution to journalArticle

Taniguchi, M, Fukagawa, M, Fujii, N, Hamano, T, Shoji, T, Yokoyama, K, Nakai, S, Shigematsu, T, Iseki, K & Tsubakihara, Y 2013, 'Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients', Therapeutic Apheresis and Dialysis, vol. 17, no. 2, pp. 221-228. https://doi.org/10.1111/1744-9987.12030
Taniguchi, Masatomo ; Fukagawa, Masafumi ; Fujii, Naohiko ; Hamano, Takayuki ; Shoji, Tetsuo ; Yokoyama, Keitaro ; Nakai, Shigeru ; Shigematsu, Takashi ; Iseki, Kunitoshi ; Tsubakihara, Yoshiharu. / Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients. In: Therapeutic Apheresis and Dialysis. 2013 ; Vol. 17, No. 2. pp. 221-228.
@article{fa8146b014ad4b15a401ffea7bad4cd2,
title = "Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients",
abstract = "Mineral metabolism affects mortality in hemodialysis patients and is identified by imbalances in serum phosphate (P), calcium (Ca), and parathyroid hormone (PTH). We examined associations between annual mineral values (P, Ca, PTH) and mortality in a 3-year cohort (Dec 2006-2009) of 128125 hemodialysis patients using three models, that is, baseline, time-dependent and time-average Cox models. We also examined associations between achieved Japanese guideline targets (P: 3.5-6.0mg/dL, corrected Ca 8.4-10.0mg/dL, intact PTH 60-180mg/dL) and all-cause survival to elucidate which parameter should be controlled as a priority. High and low serum P (>6.0 or ≤3.5mg/dL), high Ca (>9.5mg/dL), higher PTH (>300pg/mL) and lower PTH (≤60pg/mL) were significantly associated with high mortality in all three models (P<0.01). When we examined the association between combination of mineral targets and mortality, patients who achieved all targets simultaneously (20{\%} of subjects, reference) showed lowest mortality. Those who achieved both P and Ca targets showed the same mortality as the reference group. Those who only met P target had a lower risk of death (hazard ratio=1.17) compared to those that achieved Ca or PTH target (1.41, 1.47, respectively). As time of achieving P and Ca targets increased, all-cause mortalities diminished incrementally, significantly. Mineral metabolism disorder would lead to high mortality in prevalent hemodialysis patients. Among mineral values, P would be the strongest predictor for high mortality. Consistent achievement of P and Ca targets would lead to good survival.",
keywords = "Chronic kidney disease-mineral and bone disorders, Guidelines, Japan, Mortality, Priority",
author = "Masatomo Taniguchi and Masafumi Fukagawa and Naohiko Fujii and Takayuki Hamano and Tetsuo Shoji and Keitaro Yokoyama and Shigeru Nakai and Takashi Shigematsu and Kunitoshi Iseki and Yoshiharu Tsubakihara",
year = "2013",
month = "4",
doi = "10.1111/1744-9987.12030",
language = "English (US)",
volume = "17",
pages = "221--228",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

AU - Taniguchi, Masatomo

AU - Fukagawa, Masafumi

AU - Fujii, Naohiko

AU - Hamano, Takayuki

AU - Shoji, Tetsuo

AU - Yokoyama, Keitaro

AU - Nakai, Shigeru

AU - Shigematsu, Takashi

AU - Iseki, Kunitoshi

AU - Tsubakihara, Yoshiharu

PY - 2013/4

Y1 - 2013/4

N2 - Mineral metabolism affects mortality in hemodialysis patients and is identified by imbalances in serum phosphate (P), calcium (Ca), and parathyroid hormone (PTH). We examined associations between annual mineral values (P, Ca, PTH) and mortality in a 3-year cohort (Dec 2006-2009) of 128125 hemodialysis patients using three models, that is, baseline, time-dependent and time-average Cox models. We also examined associations between achieved Japanese guideline targets (P: 3.5-6.0mg/dL, corrected Ca 8.4-10.0mg/dL, intact PTH 60-180mg/dL) and all-cause survival to elucidate which parameter should be controlled as a priority. High and low serum P (>6.0 or ≤3.5mg/dL), high Ca (>9.5mg/dL), higher PTH (>300pg/mL) and lower PTH (≤60pg/mL) were significantly associated with high mortality in all three models (P<0.01). When we examined the association between combination of mineral targets and mortality, patients who achieved all targets simultaneously (20% of subjects, reference) showed lowest mortality. Those who achieved both P and Ca targets showed the same mortality as the reference group. Those who only met P target had a lower risk of death (hazard ratio=1.17) compared to those that achieved Ca or PTH target (1.41, 1.47, respectively). As time of achieving P and Ca targets increased, all-cause mortalities diminished incrementally, significantly. Mineral metabolism disorder would lead to high mortality in prevalent hemodialysis patients. Among mineral values, P would be the strongest predictor for high mortality. Consistent achievement of P and Ca targets would lead to good survival.

AB - Mineral metabolism affects mortality in hemodialysis patients and is identified by imbalances in serum phosphate (P), calcium (Ca), and parathyroid hormone (PTH). We examined associations between annual mineral values (P, Ca, PTH) and mortality in a 3-year cohort (Dec 2006-2009) of 128125 hemodialysis patients using three models, that is, baseline, time-dependent and time-average Cox models. We also examined associations between achieved Japanese guideline targets (P: 3.5-6.0mg/dL, corrected Ca 8.4-10.0mg/dL, intact PTH 60-180mg/dL) and all-cause survival to elucidate which parameter should be controlled as a priority. High and low serum P (>6.0 or ≤3.5mg/dL), high Ca (>9.5mg/dL), higher PTH (>300pg/mL) and lower PTH (≤60pg/mL) were significantly associated with high mortality in all three models (P<0.01). When we examined the association between combination of mineral targets and mortality, patients who achieved all targets simultaneously (20% of subjects, reference) showed lowest mortality. Those who achieved both P and Ca targets showed the same mortality as the reference group. Those who only met P target had a lower risk of death (hazard ratio=1.17) compared to those that achieved Ca or PTH target (1.41, 1.47, respectively). As time of achieving P and Ca targets increased, all-cause mortalities diminished incrementally, significantly. Mineral metabolism disorder would lead to high mortality in prevalent hemodialysis patients. Among mineral values, P would be the strongest predictor for high mortality. Consistent achievement of P and Ca targets would lead to good survival.

KW - Chronic kidney disease-mineral and bone disorders

KW - Guidelines

KW - Japan

KW - Mortality

KW - Priority

UR - http://www.scopus.com/inward/record.url?scp=84875766786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875766786&partnerID=8YFLogxK

U2 - 10.1111/1744-9987.12030

DO - 10.1111/1744-9987.12030

M3 - Article

C2 - 23551679

AN - SCOPUS:84875766786

VL - 17

SP - 221

EP - 228

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 2

ER -